![leucemia linfatica cronica: 'da malattia inguaribile a sopravvivenza che supera oggi i 10 anni dalla diagnosi, grazie alle nuove scoperte' leucemia linfatica cronica: 'da malattia inguaribile a sopravvivenza che supera oggi i 10 anni dalla diagnosi, grazie alle nuove scoperte'](https://citynews-baritoday.stgy.ovh/~media/original-hi/56229794210363/leucemia-linfatica-cronica-da-malattia-inguaribile-a-sopravvivenza-che-supera-oggi-i-10-anni-dalla-diagnosi-grazie-alle-nuove-scoperte.jpg)
leucemia linfatica cronica: 'da malattia inguaribile a sopravvivenza che supera oggi i 10 anni dalla diagnosi, grazie alle nuove scoperte'
![Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele. Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele.](https://data08.123doks.com/thumbv2/123dokorg/000/327/327960/cover.webp)
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele.
![PDF) The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: A seven-year update of the GIMEMA 0496 trial PDF) The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: A seven-year update of the GIMEMA 0496 trial](https://i1.rgstatic.net/publication/7247723_The_role_of_BCRABL_isoforms_in_the_presentation_and_outcome_of_patients_with_Philadelphia-positive_acute_lymphoblastic_leukemia_A_seven-year_update_of_the_GIMEMA_0496_trial/links/0912f510be08e99595000000/largepreview.png)
PDF) The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: A seven-year update of the GIMEMA 0496 trial
![PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/50741349/mini_magick20190127-13551-1so7by0.png?1548645327)
PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu
![Congenital hemoglobinopathies: scientific updates and services organization for the sickle cell disease - Fondazione Gianni Benzi Onlus Congenital hemoglobinopathies: scientific updates and services organization for the sickle cell disease - Fondazione Gianni Benzi Onlus](https://www.benzifoundation.org/wp-content/uploads/2019/02/SCD_Marzo-1080x675.jpg)
Congenital hemoglobinopathies: scientific updates and services organization for the sickle cell disease - Fondazione Gianni Benzi Onlus
![Nuovo approccio per il monitoraggio della leucemia linfatica cronica: nel gruppo di ricerca, la biologa di Trani Luciana Impera - ilgiornaleditrani Nuovo approccio per il monitoraggio della leucemia linfatica cronica: nel gruppo di ricerca, la biologa di Trani Luciana Impera - ilgiornaleditrani](https://www.ilgiornaleditrani.net/wp-content/uploads/2020/07/10739img1.jpg)